Corsellis JA, Goldberg GJ, Norton AR (1968) “Limbic encephalitis” and its association with carcinoma. Brain 91(3):481–496
CAS
PubMed
Google Scholar
Irani SR, Gelfand JM, Al-Diwani A, Vincent A (2014) Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 76(2):168–184
CAS
PubMed
PubMed Central
Google Scholar
Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378(9):840–851
PubMed
Google Scholar
Ramanathan S, Mohammad SS, Brilot F, Dale RC (2014) Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci 21(5):722–730
CAS
PubMed
Google Scholar
Bien CG, Vincent A, Barnett MH et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638
PubMed
Google Scholar
Lancaster E, Dalmau J (2012) Neuronal autoantigens–pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8(7):380–390
CAS
PubMed
PubMed Central
Google Scholar
Ramanathan S, Irani SR (2018) Autoantibody-mediated forms of encephalitis. In: Reference module in neuroscience and biobehavioral psychology. Elsevier. ISBN 9780128093245
Thompson J, Bi M, Murchison AG et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141(2):348–356
PubMed
Google Scholar
Irani SR, Vincent A, Schott JM (2011) Autoimmune encephalitis. BMJ 342:d1918
PubMed
Google Scholar
Varley J, Vincent A, Irani SR (2015) Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol 262(4):1081–1095
CAS
PubMed
Google Scholar
Irani SR, Bien CG, Lang B (2011) Autoimmune epilepsies. Curr Opin Neurol 24(2):146–153
CAS
PubMed
Google Scholar
Damato V, Balint B, Kienzler AK, Irani SR (2018) The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord 33(9):1376–1389
PubMed
PubMed Central
Google Scholar
Vincent A, Irani SR, Lang B (2011) Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia 52(Suppl 8):8–11
CAS
PubMed
Google Scholar
Haselmann H, Mannara F, Werner C et al (2018) Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction. Neuron 100(1):91–105
CAS
PubMed
Google Scholar
Dubey D, Pittock SJ, Kelly CR et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):66–177
Google Scholar
Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165
CAS
PubMed
PubMed Central
Google Scholar
Machado S, Pinto AN, Irani SR (2012) What should you know about limbic encephalitis? Arq Neuropsiquiatr 70(10):817–822
PubMed
Google Scholar
Waters P, Reindl M, Saiz A et al (2016) Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry 87(9):1005–1015
PubMed
PubMed Central
Google Scholar
Waters P, Komorowski L, Woodhall M et al (2019) A multicenter comparison of MOG-IgG cell-based assays. Neurology 92(11):e1250–e1255
CAS
PubMed
PubMed Central
Google Scholar
Jezequel J, Johansson EM, Dupuis JP et al (2017) Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients. Nat Commun 8(1):1791
PubMed
PubMed Central
Google Scholar
McCracken L, Zhang J, Greene M et al (2017) Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 4(6):e404
PubMed
PubMed Central
Google Scholar
Jezequel J, Rogemond V, Pollak T et al (2017) Cell- and single molecule-based methods to detect anti-N-methyl-d-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE Project. Biol Psychiatry 82(10):766–772
CAS
PubMed
Google Scholar
Dahm L, Ott C, Steiner J et al (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76(1):82–94
CAS
PubMed
Google Scholar
Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67–76
CAS
PubMed
Google Scholar
Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17(9):760–772
PubMed
PubMed Central
Google Scholar
Kreye J, Wenke NK, Chayka M et al (2016) Human cerebrospinal fluid monoclonal N-methyl-d-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain 139:2641–2652
PubMed
Google Scholar
van Sonderen A, Thijs RD, Coenders EC et al (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87(14):1449–1456
PubMed
Google Scholar
Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391–404
PubMed
PubMed Central
Google Scholar
Lee WJ, Lee ST, Byun JI et al (2016) Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 86(18):1683–1691
CAS
PubMed
Google Scholar
Armangue T, Titulaer MJ, Sabater L et al (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75(3):435–441
PubMed
Google Scholar
Gable MS, Sheriff H, Dalmau J et al (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54(7):899–904
CAS
PubMed
PubMed Central
Google Scholar
Vitaliani R, Mason W, Ancs B et al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58(4):594–604
PubMed
PubMed Central
Google Scholar
Dalmau J, Tuzun E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36
CAS
PubMed
PubMed Central
Google Scholar
Dalmau J, Gleichman A, Hughes E et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098
CAS
PubMed
PubMed Central
Google Scholar
Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74
CAS
PubMed
PubMed Central
Google Scholar
Biancheri R, Pessagno A, Baglietto MG et al (2010) Anti-N-methyl-D-aspartate-receptor encephalitis in a four-year-old girl. J Pediatr 156(2):332–334
CAS
PubMed
Google Scholar
Okamura H, Oomori N, Uchitomi Y (1997) An acutely confused 15-year-old girl. Lancet 350(9076):488
CAS
PubMed
Google Scholar
Kamei S, Kuzuhara S, Ishihara M et al (2009) Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-d-aspartate receptor encephalitis. Intern Med 48(9):673–679
PubMed
Google Scholar
Dale RC, Irani SR, Brilot F et al (2009) N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 66(5):704–709
CAS
PubMed
Google Scholar
Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667
PubMed
PubMed Central
Google Scholar
Hacohen Y, Deiva K, Pettingill P et al (2014) N-methyl-d-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 29(1):90–96
CAS
PubMed
Google Scholar
Armangue T, Leypoldt F, Malaga I et al (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75(2):317–323
CAS
PubMed
PubMed Central
Google Scholar
Balint B, Vincent A, Meinck HM et al (2018) Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology. Brain 141(1):13–36
PubMed
Google Scholar
Mohammad SS, Fung VSC, Grattan-Smith P et al (2014) Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord 29(12):1539–1542
CAS
PubMed
Google Scholar
Baizabal-Carvallo JF, Stocco A, Muscal E et al (2013) The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 28(4):543–547
PubMed
Google Scholar
Varley JA, Webb AJS, Balint B et al (2018) The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study. J Neurol Neurosurg Psychiatry 90(6):724–726
PubMed
PubMed Central
Google Scholar
Al-Diwani A, Handel A, Townsend L et al (2019) The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry 6(3):235–246
PubMed
PubMed Central
Google Scholar
Warren N, Siskind D, O’Gorman C (2018) Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatr Scand 138(5):401–408
CAS
PubMed
Google Scholar
Gibson LL, Pollak TA, Blackman G et al (2019) The psychiatric phenotype of anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci 31(1):70–79
PubMed
Google Scholar
Al-Diwani AAJ, Pollak TA, Irani SR et al (2017) Psychosis: an autoimmune disease? Immunology 152(3):388–401
CAS
PubMed
PubMed Central
Google Scholar
Armangue T, Santamaria J, Dalmau J (2015) When a serum test overrides the clinical assessment. Neurology 84(13):1379–1381
PubMed
PubMed Central
Google Scholar
Mikasova L, De Rossi P, Bouchet D et al (2012) Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 135:1606–1621
PubMed
Google Scholar
Planaguma J, Haselmann H, Mannara F et al (2016) Ephrin-B2 prevents N-methyl-d-aspartate receptor antibody effects on memory and neuroplasticity. Ann Neurol 80(3):388–400
CAS
PubMed
PubMed Central
Google Scholar
Ladepeche L, Planaguma J, Thakur S et al (2018) NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors. Cell Rep 23(13):3759–3768
CAS
PubMed
PubMed Central
Google Scholar
Finke C, Kopp UA, Scheel M et al (2013) Functional and structural brain changes in anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 74(2):284–296
CAS
PubMed
Google Scholar
Peer M, Pruss H, Ben-Dayan I et al (2017) Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 4(10):768–774
PubMed
Google Scholar
Karadottir R, Cavelier P, Bergersen LH et al (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438(7071):1162–1166
CAS
PubMed
PubMed Central
Google Scholar
Balu R, McCracken L, Lancaster E et al (2019) A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92(3):e244–e252
PubMed
PubMed Central
Google Scholar
Lim JA, Lee ST, Moon J et al (2019) Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 85(3):352–358
PubMed
Google Scholar
Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan’s syndrome and acquired neuromyotonia. Brain 133(9):2734–2748
PubMed
PubMed Central
Google Scholar
Lai M, Huijbers MG, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9(8):776–785
CAS
PubMed
PubMed Central
Google Scholar
Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol 82(1):79–92
CAS
PubMed
Google Scholar
Lopez-Chiriboga AS, Klein C, Zekeridou A et al (2018) LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol 84(3):473–480
CAS
PubMed
Google Scholar
Klein CJ, Lennon VA, Aston PA et al (2013) Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 70(2):229–234
PubMed
PubMed Central
Google Scholar
Lang B, Makuch M, Moloney T et al (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry 88(4):353–361
PubMed
PubMed Central
Google Scholar
van Sonderen A, Schreurs MW, de Bruijn MA et al (2016) The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology 86:1692–1699
PubMed
Google Scholar
Ramanathan S, Irani SR (2018) Anti-LGI1 encephalitis. Medlink neurology. MedLink Corporation, San Diego
Google Scholar
Kim TJ, Lee ST, Moon J et al (2017) Anti-LGI1 encephalitis is associated with unique HLA subtypes. Ann Neurol 81(2):183–192
CAS
PubMed
Google Scholar
van Sonderen A, Roelen DL, Stoop JA et al (2017) Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol 81(2):193–198
PubMed
Google Scholar
Binks S, Varley J, Lee W et al (2018) Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain 141(8):2263–2271
PubMed
PubMed Central
Google Scholar
Irani SR, Michell AW, Lang B et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69(5):892–900
PubMed
Google Scholar
Irani SR, Stagg CJ, Schott JM et al (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136:3151–3162
PubMed
Google Scholar
Finke C, Pruss H, Heine J et al (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74(1):50–59
PubMed
Google Scholar
Miller TD, Chong TT, Davies AM et al (2017) Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis. Brain 140(5):1212–1219
PubMed
PubMed Central
Google Scholar
Aurangzeb S, Symmonds M, Knight RK et al (2017) LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure 50:14–17
PubMed
PubMed Central
Google Scholar
Naasan G, Irani SR, Bettcher BM et al (2014) Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol 71(10):1300–1304
PubMed
PubMed Central
Google Scholar
Bakpa OD, Reuber M, Irani SR (2016) Antibody-associated epilepsies: clinical features, evidence for immunotherapies and future research questions. Seizure 41:26–41
PubMed
PubMed Central
Google Scholar
Flanagan EP, Kotsenas AL, Britton JW et al (2015) Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm 2(6):e161
PubMed
PubMed Central
Google Scholar
Navarro V, Kas A, Apartis E et al (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139:1079–1093
PubMed
Google Scholar
Irani SR, Gelfand JM, Bettcher BM et al (2014) Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol 71(7):896–900
PubMed
PubMed Central
Google Scholar
van Sonderen A, Schreurs MW, Wirtz PW et al (2016) From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev 15(10):970–974
PubMed
Google Scholar
Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241–255
PubMed
Google Scholar
Grau-Rivera O, Sanchez-Valle R, Saiz A et al (2014) Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease. JAMA Neurol 71(1):74–78
PubMed
PubMed Central
Google Scholar
Nosadini M, Mohammad SS, Ramanathan S et al (2015) Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 15(12):1391–1419
CAS
PubMed
Google Scholar
Dubey D, Blackburn K, Greenberg B et al (2016) Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. Expert Rev Neurother 16(8):937–949
CAS
PubMed
Google Scholar
Lee WJ, Lee ST, Moon J et al (2016) Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 13(4):824–832
CAS
PubMed
PubMed Central
Google Scholar
Behrendt V, Krogias C, Reinacher-Schick A et al (2016) Bortezomib treatment for patients with anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 73(10):1251–1253
PubMed
Google Scholar
Planaguma J, Leypoldt F, Mannara F et al (2015) Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138:94–109
PubMed
Google Scholar
Hughes EG, Peng X, Gleichman AJ et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866–5875
CAS
PubMed
PubMed Central
Google Scholar
Gleichman AJ, Spruce LA, Dalmau J et al (2012) Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 32(32):11082–11094
CAS
PubMed
PubMed Central
Google Scholar
Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65(4):424–434
CAS
PubMed
PubMed Central
Google Scholar
Carvajal-Gonzalez A, Leite MI, Waters P et al (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137:2178–2192
PubMed
PubMed Central
Google Scholar
Pettingill P, Kramer HB, Coebergh JA et al (2015) Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology 84(12):1233–1241
CAS
PubMed
PubMed Central
Google Scholar
Nibber A, Mann EO, Pettingill P et al (2017) Pathogenic potential of antibodies to the GABAB receptor. Epilepsia Open 2(3):355–359
PubMed
PubMed Central
Google Scholar
Dabner M, McCluggage WG, Bundell C et al (2012) Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 31(5):429–437
PubMed
Google Scholar
Day GS, Laiq S, Tang-Wai DR et al (2014) Abnormal neurons in teratomas in NMDAR encephalitis. JAMA Neurol 71(6):717–724
PubMed
Google Scholar
Makuch M, Wilson R, Al-Diwani A et al (2018) N-methyl-d-aspartate receptor antibody production from germinal center reactions: therapeutic implications. Ann Neurol 83(3):553–561
CAS
PubMed
PubMed Central
Google Scholar
Mohammad SS, Sinclair K, Pillai S et al (2014) Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-d-aspartate receptor or dopamine-2 receptor. Mov Disord 29(1):117–122
CAS
PubMed
Google Scholar
Pruss H, Finke C, Holtje M et al (2012) N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72(6):902–911
PubMed
PubMed Central
Google Scholar
Pruss H (2017) Postviral autoimmune encephalitis: manifestations in children and adults. Curr Opin Neurol 30(3):327–333
PubMed
Google Scholar
Linnoila J, Pulli B, Armangue T et al (2019) Mouse model of anti-NMDA receptor post-herpes simplex encephalitis. Neurol Neuroimmunol Neuroinflamm 6(2):e529
PubMed
Google Scholar
Wilson R, Makuch M, Kienzler AK et al (2018) Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica. Brain 141(4):1063–1074
PubMed
PubMed Central
Google Scholar
Wenke NK, Kreye J, Andrzejak E et al (2019) N-methyl-d-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Ann Neurol 85(5):771–776
CAS
PubMed
PubMed Central
Google Scholar
Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88(18):1736–1743
CAS
PubMed
PubMed Central
Google Scholar
Mueller SH, Farber A, Pruss H et al (2018) Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol 83(4):863–869
CAS
PubMed
Google Scholar
Bergink V, Armangue T, Titulaer MJ et al (2015) Autoimmune encephalitis in postpartum psychosis. Am J Psychiatry 172(9):901–908
PubMed
PubMed Central
Google Scholar
Kayser MS, Titulaer MJ, Gresa-Arribas N et al (2013) Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 70(9):1133–1139
PubMed
Google Scholar
Gillinder L, Warren N, Hartel G et al (2019) EEG findings in NMDA encephalitis—a systematic review. Seizure 65:20–24
PubMed
Google Scholar
Binks S, Klein CJ, Waters P et al (2018) LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 89(5):526–534
PubMed
Google Scholar
Hutchinson M, Waters P, McHugh J et al (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71(16):1291–1292
CAS
PubMed
Google Scholar
Mas N, Saiz A, Leite MI et al (2011) Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 82(12):1399–1401
PubMed
Google Scholar
McKeon A, Martinez-Hernandez E, Lancaster E et al (2013) Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 70(1):44–50
PubMed
PubMed Central
Google Scholar
Ohkawa T, Satake S, Yokoi N et al (2014) Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci 34(24):8151–8163
PubMed
PubMed Central
Google Scholar
Petit-Pedrol M, Armangue T, Peng X et al (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13(3):276–286
CAS
PubMed
PubMed Central
Google Scholar
Boronat A, Sabater L, Saiz A et al (2011) GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76(9):795–800
CAS
PubMed
PubMed Central
Google Scholar
Alexopoulos H, Dagklis IE, Akrivou S et al (2014) Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression. Neurol Neuroimmunol Neuroinflamm 1(4):e39
PubMed
PubMed Central
Google Scholar
Onugoren MD, Deuretzbacher D, Haensch CA et al (2015) Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry 86(9):965–972
Google Scholar
Lancaster E, Martinez-Hernandez E, Titulaer MJ et al (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698–1701
CAS
PubMed
PubMed Central
Google Scholar
Nicoletti F, Bockaert J, Collingridge GL et al (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60(7–8):1017–1041
CAS
PubMed
Google Scholar
Boronat A, Gelfand JM, Gresa-Arribas N et al (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73(1):120–128
CAS
PubMed
Google Scholar
Tobin WO, Lennon VA, Komorowski L et al (2014) DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 83(20):1797–1803
CAS
PubMed
PubMed Central
Google Scholar
Piepgras J, Holtje M, Michel K et al (2015) Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology 85(10):890–897
CAS
PubMed
PubMed Central
Google Scholar
Dale RC, Merheb V, Pillai S et al (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453–3468
PubMed
Google Scholar
Sinmaz N, Tea F, Pilli D et al (2016) Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders. Acta Neuropathol Commun 4(1):126
PubMed
PubMed Central
Google Scholar
Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13(6):575–586
CAS
PubMed
PubMed Central
Google Scholar
Gelpi E, Hoftberger R, Graus F et al (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132(4):531–543
CAS
PubMed
PubMed Central
Google Scholar
Honorat JA, Komorowski L, Josephs KA et al (2017) IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm 4(5):e385
PubMed
PubMed Central
Google Scholar
Gresa-Arribas N, Planaguma J, Petit-Pedrol M et al (2016) Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development. Neurology 86(24):2235–2242
CAS
PubMed
PubMed Central
Google Scholar
Berridge G, Menassa DA, Moloney T et al (2018) Glutamate receptor delta2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology 91(8):e714–e723
CAS
PubMed
PubMed Central
Google Scholar
Al-Diwani A, Linighan R, Perkins C et al (2019) 25 On being autoimmune in psychiatric places: 10 characteristic mental state features in patients with definite NMDAR-antibody encephalitis. J Neurol Neurosurg Psychiatry 90:A11–A12
Google Scholar